In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral and intravenous administration.
By integrating solubility and permeability, the Biopharmaceutical Classification System highlights how transporters influence drug disposition; for instance, Class II drugs face significant challenges due to efflux into the gastrointestinal lumen and biliary excretion.
In the liver's bile canaliculi, modification of influx and efflux transporters can influence intrinsic clearance.
Transporters play a major role in moving drugs within liver cells. Elaborate models, such as the biopharmaceutical drug disposition classification system, are essential to relate transporters to drug disposition.
It categorizes drugs into four classes based on solubility and permeability. This system provides insights into elimination routes and effects of transporters following oral and intravenous administration.
For instance, Class 1 drugs are less affected by transporters due to their good absorption, which results from high solubility and permeability.
In contrast, Class 2 drugs are highly affected by efflux transporters due to low solubility and high permeability. It results in limited drug absorption and potential efflux back into the gastrointestinal lumen, lowering plasma drug concentration.
Additionally, efflux transporters in the liver canaliculi pump these drugs into the bile.